InvestorsHub Logo
Followers 240
Posts 12122
Boards Moderated 0
Alias Born 08/14/2003

Re: None

Saturday, 06/19/2021 1:58:49 PM

Saturday, June 19, 2021 1:58:49 PM

Post# of 691155
Just a thought, right now no company sponsored trial for DCVax-L is active, the only DCVax-L being made is either at UCLA or for compassionate use in Europe. I wonder if the FlaskWork device might be utilized in either of these places to validate it's capabilities.

I really believe that the FlaskWork device will be a game changer that will greatly lower the cost of many personalized drugs which normally could only be done in a cell line located in a clean room. I gather that the FlaskWork device is very adaptable to a variety of products, not limited to the DCVax's. In time, I believe the sale, or lease, of the device will make it a major profit center for the company. I would suspect that lease would better describe how the company will choose to operate, the lease would include a specified number of cassettes, when all cassettes were utilized the unit would either be returned, or a lease modification would provide additional cassettes.

I believe that by the time the next DCVax-Direct trial is initiated, all trial product will be made using the FlaskWork device. If I'm right about this, all questions about it's future production will have been answered.

Gary
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News